Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLP1R | P43220 | 6/20 | 0.71 |
| ▸ | ECE1 | P42892 | 1/20 | 0.71 |
| ▸ | MUS81 | Q96NY9 | 1/20 | 0.71 |
| ▸ | PTH1R | Q03431 | 8/20 | 0.70 |
| ▸ | CCKBR | P32239 | 1/20 | 0.67 |
| ▸ | NR3C1 | P04150 | 4/20 | 0.66 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.66 |
| ▸ | NPY1R | P25929 | 1/20 | 0.64 |
| ▸ | NPY2R | P49146 | 1/20 | 0.64 |
| ▸ | NPY4R | P50391 | 1/20 | 0.64 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31396476 | 0.91 | PTH1R (0.74) | GLP1RECE1MUS81PTH1RCCKBR | |
| SCHEMBL30148541 | 0.90 | NR3C1 (0.74) | GLP1RECE1MUS81PTH1RCCKBR | |
| SCHEMBL30411571 | 0.90 | PTH1R (0.77) | GLP1RECE1MUS81PTH1RCCKBR | |
| SCHEMBL31060658 | 0.89 | GLP1R (0.89) | GLP1RECE1MUS81PTH1RCCKBR | |
| Glp-1 SCHEMBL29353361 | 0.89 | GLP1R (0.89) | GLP1RECE1MUS81PTH1RCCKBR | |
| SCHEMBL29412274 | 0.89 | GLP1R (0.73) | GLP1RECE1MUS81PTH1RCCKBR | |
| SCHEMBL30408986 | 0.89 | PTH1R (0.67) | GLP1RECE1MUS81PTH1RCCKBR | |
| SCHEMBL31664368 | 0.89 | RXFP1 (0.68) | GLP1RECE1MUS81PTH1RCCKBR | |
| SCHEMBL30744286 | 0.88 | NR3C1 (0.71) | GLP1RECE1MUS81PTH1RCCKBR | |
| Dermaseptin S1 SCHEMBL30063560 | 0.88 | PTH1R (0.68) | GLP1RECE1MUS81PTH1RCCKBR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122050711-A | Alpha-linolenic acid personalized supplementation judging method and system based on fatty acid metabolism related genotype | 华中科技大学 | 2026-05-15 | — | — | CN | disclosed |
| CN-120137138-A | Polyurethane foam material, preparation method thereof and battery pack | 湖北祥源新材科技股份有限公司 | 2025-06-13 | — | — | CN | disclosed |
| CN-119279230-A | Rice starch-chickpea protein hydrolysate compound with digestion resistance function and preparation method thereof | 东北农业大学 | 2025-01-10 | — | — | CN | disclosed |
| CN-118440907-A | Phage RSP2307003 aiming at strong-drug-resistance bacterial wilt, and composition and application thereof | 武汉格瑞农生物科技有限公司 | 2024-08-06 | — | — | CN | disclosed |
| CN-115725512-B | Ralstonia solanaceae phage and composition, kit and application thereof | 菲吉乐科(南京)生物科技有限公司 | 2024-07-26 | — | — | CN | disclosed |
| CN-117813355-A | Pigment compositions, coloring compositions, coatings, inks, ink sets, prints and packaging materials | 爱天思株式会社 | 2024-04-02 | — | — | CN | disclosed |
| CN-117625239-A | Method for producing aromatic hydrocarbon and isoparaffin gasoline | 中国石油化工股份有限公司 | 2024-03-01 | — | — | CN | disclosed |
| US-11844049-B2 | Terminal, wireless communication system, and base station for selecting a radio resource based on a result of sensing | FUJITSU LIMITED (JP) | 2023-12-12 | — | — | US | disclosed |
| CN-112673698-B | Terminal, wireless communication system and base station | 富士通株式会社 | 2023-11-28 | — | — | CN | disclosed |
| US-20230130980-A1 | HIGH PENETRATION PRODRUG COMPOSITIONS OF ANTIMICROBIALS AND ANTIMICROBIAL-RELATED COMPOUNDS | TECHFIELDS PHARMA CO., LTD. (CN) | 2023-04-27 | — | — | US | disclosed |
| CN-115725512-A | Ralstonia solanacearum bacteriophage and composition, kit and application thereof | 菲吉乐科(南京)生物科技有限公司 | 2023-03-03 | — | — | CN | disclosed |
| US-11485744-B2 | High penetration prodrug compositions of antimicrobials and antimicrobial-related compounds | TECHFIELDS PHARMA CO., LTD. (CN) | 2022-11-01 | — | — | US | disclosed |
| CN-109154609-B | Composite particle, coated particle, method for producing composite particle, solid phase carrier containing ligand, and method for detecting or separating target substance in sample | JSR株式会社 | 2022-08-05 | — | — | CN | disclosed |
| CN-112705118-B | Heavy oil hydrogenation reactor and hydrogenation process | 中国石油化工股份有限公司 | 2022-07-12 | — | — | CN | disclosed |
| CN-112705120-B | Heavy oil processing device and processing method | 中国石油化工股份有限公司 | 2022-07-08 | — | — | CN | disclosed |
| US-11237162-B2 | Composite particles, coated particles, method for producing composite particles, ligand-containing solid phase carrier and method for detecting or separating target substance in sample | JSR CORPORATION (JP) | 2022-02-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11485744-B2 | High penetration prodrug compositions of antimicrobials and antimicrobial-related compounds | SLC7A1, VIP, HPGDS | GLP1R 558/4885ECE1 1643/4885MUS81 4322/4885 |
| US-20230130980-A1 | HIGH PENETRATION PRODRUG COMPOSITIONS OF ANTIMICROBIALS AND ANTIMICROBIAL-RELATED COMPOUNDS | SLC7A1, VIP, HPGDS | GLP1R 558/4885ECE1 1643/4885MUS81 4322/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.